BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 24626868)

  • 21. Nonhuman primate and human challenge models of pertussis.
    Merkel TJ; Halperin SA
    J Infect Dis; 2014 Apr; 209 Suppl 1(Suppl 1):S20-3. PubMed ID: 24626867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Changing from whole-cell to acellular pertussis vaccines would trade superior tolerability for inferior protection.
    Herzog C
    Expert Rev Vaccines; 2015; 14(8):1065-72. PubMed ID: 26098640
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Pertussis vaccine. Reemergence of the disease and new vaccination strategies].
    Moraga-Llop FA; Campins-Martí M
    Enferm Infecc Microbiol Clin; 2015 Mar; 33(3):190-6. PubMed ID: 25707329
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pertussis vaccines for adolescents and adults.
    Cherry JD
    Pediatrics; 2005 Sep; 116(3):755-6. PubMed ID: 16140719
    [No Abstract]   [Full Text] [Related]  

  • 26. Live attenuated vaccines against pertussis.
    Locht C; Mielcarek N
    Expert Rev Vaccines; 2014 Sep; 13(9):1147-58. PubMed ID: 25085735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. What to do about pertussis vaccines? Linking what we know about pertussis vaccine effectiveness, immunology and disease transmission to create a better vaccine.
    Bolotin S; Harvill ET; Crowcroft NS
    Pathog Dis; 2015 Nov; 73(8):ftv057. PubMed ID: 26253079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Priming with whole-cell versus acellular pertussis vaccine.
    Liko J; Robison SG; Cieslak PR
    N Engl J Med; 2013 Feb; 368(6):581-2. PubMed ID: 23388023
    [No Abstract]   [Full Text] [Related]  

  • 29. The United States research strategy on pertussis.
    La Montagne JR
    Dev Biol Stand; 1997; 89():25-8. PubMed ID: 9272332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pertussis control: time for something new?
    Clark TA; Messonnier NE; Hadler SC
    Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduced risk of pertussis among persons ever vaccinated with whole cell pertussis vaccine compared to recipients of acellular pertussis vaccines in a large US cohort.
    Witt MA; Arias L; Katz PH; Truong ET; Witt DJ
    Clin Infect Dis; 2013 May; 56(9):1248-54. PubMed ID: 23487373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The control of pertussis--2007 and beyond.
    Halperin SA
    N Engl J Med; 2007 Jan; 356(2):110-3. PubMed ID: 17215528
    [No Abstract]   [Full Text] [Related]  

  • 33. Immune responses to pertussis vaccines and disease.
    Edwards KM; Berbers GA
    J Infect Dis; 2014 Apr; 209 Suppl 1():S10-5. PubMed ID: 24158958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pertussis Across the Globe: Recent Epidemiologic Trends From 2000 to 2013.
    Tan T; Dalby T; Forsyth K; Halperin SA; Heininger U; Hozbor D; Plotkin S; Ulloa-Gutierrez R; Wirsing von König CH
    Pediatr Infect Dis J; 2015 Sep; 34(9):e222-32. PubMed ID: 26376316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Shortcomings of pertussis vaccines: why we need a third generation vaccine.
    Poolman JT
    Expert Rev Vaccines; 2014 Oct; 13(10):1159-62. PubMed ID: 25089373
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining long-term drivers of pertussis resurgence, and optimal vaccine control strategies.
    Campbell PT; McCaw JM; McIntyre P; McVernon J
    Vaccine; 2015 Oct; 33(43):5794-5800. PubMed ID: 26392008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Has the change to acellular pertussis vaccine improved or worsened pertussis control?
    Halperin SA; De Serres G
    CMAJ; 2006 Nov; 175(10):1227. PubMed ID: 17098952
    [No Abstract]   [Full Text] [Related]  

  • 38. Re-emergence of diphtheria and pertussis: implications for Nigeria.
    Sadoh AE; Oladokun RE
    Vaccine; 2012 Nov; 30(50):7221-8. PubMed ID: 23102975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Whooping cough in adults: an update on a reemerging infection.
    Paisley RD; Blaylock J; Hartzell JD
    Am J Med; 2012 Feb; 125(2):141-3. PubMed ID: 22269615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic review of the effects of pertussis vaccines in children.
    Simondon F
    Vaccine; 2004 Aug; 22(23-24):2965. PubMed ID: 15297044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.